Health Condition 1: C30-C39- Malignant neoplasms of respiratory and intrathoracic organs
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: Nil: Nil
Sponsors
Gopesh Soni
Eligibility
Inclusion criteria
Inclusion criteria: All Adult (above 18 years) Patients undergoing chemotherapy in the day care setting at the tertiary care cancer centre Patients who provide informed consent for participation in the study
Exclusion criteria
Exclusion criteria: Patients receiving concurrent radiotherapy or immunotherapy in addition to chemotherapy (to avoid confounding due to overlapping toxicities). Patients with known hypersensitivity to any of the chemotherapeutic agents before initiation of treatment. Patients on palliative or end-of-life care, where ADR assessment may be confounded by disease progression. Patients with pre-existing severe organ dysfunction (e.g., hepatic or renal impairment) that could independently predispose to drug toxicity. Patients receiving investigational or unapproved drugs as part of a clinical trial during the study period. Pregnant or lactating women, since chemotherapy safety profiles differ in this population. Patients who leave against medical advice (LAMA) or are lost to follow-up before completion of chemotherapy cycle assessment. Patients with incomplete medical records or missing ADR documentation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine the incidence of acute drug reactions among patients undergoing chemotherapy in the day care setting. Timepoint: 1 Year | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the types and patterns of acute adverse drug reactions associated with different chemotherapy regimens. To evaluate the severity of drug reactions using standard grading criteria (WHO-UMC scale) To assess the management strategies for acute drug reactions in the day care chemotherapy setting. Timepoint: 1 Year | — |
Countries
India
Contacts
Public ContactGopesh Soni
Mahatma Gandhi Medical College, Jaipur, Rajasthan
Outcome results
None listed